Source: Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Imran Sulaiman, Garrett Greene, Elaine MacHale, Jansen Seheult, Matshediso Mokoka, Shona D'Arcy, Terence Taylor, Desmond M. Murphy, Eoin Hunt, Stephen J. Lane, Gregory B. Diette, J. Mark FitzGerald, Fiona Boland, Aoife Sartini Bhreathnach, Breda Cushen, Richard B. Reilly, Frank Doyle, Richard W. Costello. A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma. Eur Respir J, 51 (1) 1701126; 10.1183/13993003.01126-2017

Member's Comments

No comment yet.

Related content which might interest you: A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients Source: Eur Respir J, 57 (6) 2003103; 10.1183/13993003.03103-2020 Year: 2021 Effectiveness of a pharmacist-led inhalation technique intervention on asthma and COPD patients: The INspira cluster-randomized controlled trial Source: Virtual Congress 2021 – Highlights for primary care in 2021 Year: 2021 Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial> Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017 A randomized cross-over study of user satisfaction with inhalant devices in asthma patients Source: International Congress 2019 – Innovations in primary care assessment and management Year: 2019 Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019 Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Efficacy of a comprehensive education program including inhaler training and COPD management during hospitalization of AECOPD, a randomized controlled clinical Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018 A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009 Efficacy of azithromycin in severe asthma from the AMAZES randomised trial Source: ERJ Open Res, 5 (4) 00056-2019; 10.1183/23120541.00056-2019 Year: 2019 A proof-of-concept randomized-controlled trial of omalizumab in patients with severe difficult to control nonatopic asthma Source: Annual Congress 2012 - Clinical diagnosis and treatment of adult asthma Year: 2012 Towards optimal patient selection for bronchial thermoplasty treatment in severe asthma: results from the TASMA randomized trial Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 A randomised clinical trial to assess the effect of active muscle stimulation on hospitalised patients with COPD exacerbations Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012 myAirCoach: mHealth assisted self-management in patients with uncontrolled asthma, a randomized control trial. Source: International Congress 2019 – M-health/e-health II Year: 2019 Development of a primary outcome measure for a randomised controlled trial of tight glycaemic control for COPD exacerbations Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Self-titration of inhaled corticosteroid and ß2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial Source: Eur Respir J, 56 (4) 2000170; 10.1183/13993003.00170-2020 Year: 2020 A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019 Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial Source: Virtual Congress 2021 – New trends in non-invasive respiratory support Year: 2021